2-Methylthioadenosine triphosphate tetrasodium saltP2 purinergic agonist CAS# 100020-57-3 |
2D Structure
- ABT-751 (E7010)
Catalog No.:BCC1085
CAS No.:141430-65-1
- CHM 1
Catalog No.:BCC2387
CAS No.:154554-41-3
- Podophyllotoxin
Catalog No.:BCN5957
CAS No.:518-28-5
- D-64131
Catalog No.:BCC1510
CAS No.:74588-78-6
- CYT997 (Lexibulin)
Catalog No.:BCC4601
CAS No.:917111-44-5
- MPC 6827 hydrochloride
Catalog No.:BCC8040
CAS No.:917369-31-4
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 100020-57-3 | SDF | Download SDF |
PubChem ID | 16218831 | Appearance | Powder |
Formula | C11H14N5Na4O13P3S | M.Wt | 641.2 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | 2-Methylthio-ATP | ||
Solubility | Soluble to 100 mM in water | ||
Chemical Name | 2-Methylthioadenosine-5'-triphosphat | ||
SMILES | CSC1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O.[Na+].[Na+].[Na+].[Na+] | ||
Standard InChIKey | UEEFBRHXFDJPTA-KWIZKVQNSA-J | ||
Standard InChI | InChI=1S/C11H18N5O13P3S.4Na/c1-33-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(27-10)2-26-31(22,23)29-32(24,25)28-30(19,20)21;;;;/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H,24,25)(H2,12,14,15)(H2,19,20,21);;;;/q;4*+1/p-4/t4-,6-,7-,10-;;;;/m1..../s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | P2 purinoceptor agonist. |
2-Methylthioadenosine triphosphate tetrasodium salt Dilution Calculator
2-Methylthioadenosine triphosphate tetrasodium salt Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.5596 mL | 7.7979 mL | 15.5958 mL | 31.1915 mL | 38.9894 mL |
5 mM | 0.3119 mL | 1.5596 mL | 3.1192 mL | 6.2383 mL | 7.7979 mL |
10 mM | 0.156 mL | 0.7798 mL | 1.5596 mL | 3.1192 mL | 3.8989 mL |
50 mM | 0.0312 mL | 0.156 mL | 0.3119 mL | 0.6238 mL | 0.7798 mL |
100 mM | 0.0156 mL | 0.078 mL | 0.156 mL | 0.3119 mL | 0.3899 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Dauriporphinoline
Catalog No.:BCN7901
CAS No.:100009-82-3
- Anisole
Catalog No.:BCN2619
CAS No.:100-66-3
- Benzaldehyde
Catalog No.:BCN8529
CAS No.:100-52-7
- Benzylamine
Catalog No.:BCN1789
CAS No.:100-46-9
- Pentamidine
Catalog No.:BCC3836
CAS No.:100-33-4
- 4-Methoxybenzoic acid
Catalog No.:BCN3838
CAS No.:100-09-4
- A-867744
Catalog No.:BCC1324
CAS No.:1000279-69-5
- GIP (human)
Catalog No.:BCC5870
CAS No.:100040-31-1
- TAK-875
Catalog No.:BCC3702
CAS No.:1000413-72-8
- 8-Hydroxy-3,5,6,7,3',4'-hexamethoxyflavone
Catalog No.:BCN7870
CAS No.:1000415-56-4
- AS 19
Catalog No.:BCC7218
CAS No.:1000578-26-6
- KW 2449
Catalog No.:BCC2179
CAS No.:1000669-72-6
- Stilbostemin N
Catalog No.:BCN4741
CAS No.:1000676-45-8
- Tegobuvir
Catalog No.:BCC1991
CAS No.:1000787-75-6
- 7-Hydroxy-2',5,8-trimethoxyflavanone
Catalog No.:BCN5817
CAS No.:100079-34-3
- 2',4'-Dihydroxy-2,3',6'-trimethoxychalcone
Catalog No.:BCN1643
CAS No.:100079-39-8
- H-Lys(Tfa)-OH
Catalog No.:BCC2985
CAS No.:10009-20-8
- Chloramultilide B
Catalog No.:BCN6613
CAS No.:1000995-47-0
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.[Pubmed:11171941]
Pharmacol Rev. 2001 Mar;53(1):107-18.
ATP acts as a humoral mediator to control cell function extracellularly. The receptors that mediate the actions of ATP belong to two classes, the metabotropic P2Y receptors and the transmitter-gated, ion channel P2X receptors. This review describes the structure, distribution, function, and ligand recognition characteristics of P2X receptors, which comprise seven distinct subunits that can function as both homo- and hetero- polymers. The pharmacology of P2X receptors is complicated by marked differences between species orthologues. The current nomenclature is based largely on recombinant receptor studies and detailed knowledge of endogenous P2X receptors in native tissues is limited because of lack of good selective agonists and antagonists for each receptor type.
Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscle.[Pubmed:9605564]
Br J Pharmacol. 1998 Apr;123(8):1579-86.
1. The effects of adenosine triphosphate (ATP), adenosine diphosphate (ADP), alpha,beta-methylene-ATP (alpha,beta-MeATP) and 2-methylthio-ATP (2-MeSATP) on longitudinally orientated smooth muscle strips from marmoset urinary bladder were investigated by use of standard organ bath techniques. 2. After being mounted in superfusion organ baths, 66.7% (n=249) of marmoset detrusor smooth muscle strips developed spontaneous tone, 48.2% of all strips examined developed tone equivalent to greater than 0.1 g mg(-1) of tissue and were subsequently utilized in the present investigation. 3. On exposure to ATP, muscle strips exhibited a biphasic response, a rapid and transient contraction followed by a more prolonged relaxation. Both responses were found to be concentration-dependent. ADP and 2-MeSATP elicited a similar response (contraction followed by relaxation), whereas application of alpha,beta-MeATP only produced a contraction. The potency order for each effect was alpha,beta-MeATP> >2-MeSATP> ATP>ADP (contractile response) and ATP=2-MeSATP> or = ADP> > alpha,beta-MeATP (relaxational response). 4. Desensitization with alpha,beta-MeATP (10 microM) abolished the contractile phase of the response to ATP, but had no effect on the level of relaxation evoked by this agonist. On the other hand, the G-protein inactivator, GDPbetaS (100 microM) abolished only the relaxation response to ATP. Suramin (general P2 antagonist, 100 microM) shifted both the contractile and relaxation ATP concentration-response curves to the right, whereas cibacron blue (P2Y antagonist, 10 microM) only antagonized the relaxation response to ATP. In contrast, the adenosine receptor antagonist, 8-phenyltheophylline (10 microM), had no effect on the relaxation response curve to ATP. 5. Incubation with tetrodotoxin (TTX, 3 microM) or depolarization of the muscle strip with 40 mM K+ Krebs failed to abolish the relaxation to ATP. In addition, neither Nomega-nitro-L-arginine (L-NOARG, 10 microM) nor methylene blue (10 microM) had any effect on the relaxation response curve. However, tos-phe-chloromethylketone (TPCK, 3 microM), an inhibitor of cyclicAMP-dependent protein kinase A (PKA), significantly (P<0.01) shifted the curve for the ATP-induced relaxation to the right. 6. It is proposed that marmoset detrusor smooth muscle contains two receptors for ATP, a classical P2X-type receptor mediating smooth muscle contraction, and a P2Y (G-protein linked) receptor mediating smooth muscle relaxation. The results also indicate that the ATP-evoked relaxation may occur through the activation of cyclicAMP-dependent PKA.
Studies on the stereoselectivity of the P2-purinoceptor.[Pubmed:6317121]
Br J Pharmacol. 1983 Aug;79(4):907-13.
ATP, 2-chloro-ATP, 2-methylthio-ATP, and their unnatural L-enantiomers, were synthesized and their effects tested on the guinea-pig taenia coli and urinary bladder, and the stimulated frog ventricle. The potent P2-purinoceptor agonists, 2-chloro-ATP and 2-methylthio-ATP were, respectively, 30 and 200 times more effective than ATP in relaxing the guinea-pig taenia, but approximately as effective as ATP in contracting the guinea-pig bladder and augmenting the force of contraction of the frog ventricle. A high degree of stereoselectivity was observed for relaxations of the guinea-pig taenia coli produced by the P2-purinoceptoragonists, and 2-methylthio-ATP was over 700 times more effective than its L-enantiomer. In contrast, stereoselectivity for contraction of the guinea-pig bladder was observed only at low concentrations with each pair of enantiomers, and a similar low stereoselectivity was displayed by the frog ventricle. These results show that P2-purinoceptors mediating inhibitory responses in the guinea-pig taenia coli can show a high degree of stereoselectivity, while P2-purinoceptors mediating excitatory responses in the guinea-pig bladder and in the frog ventricle show little stereoselectivity. The partial stereoselectivity of the P2-purinoceptor in smooth muscle contrasts with the absolute stereospecificity of P1-purinoceptors for adenosine on smooth muscle and autonomic nerve terminals and the absolute stereospecificity of the receptor for ADP on the human platelet.
Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.[Pubmed:7186826]
Br J Pharmacol. 1982 Feb;75(2):397-400.
Some 2-alkylthio derivatives of adenosine 5'-monophosphate (AMP), adenosine 5'-monophosphorothioate (AMPS) and adenosine 5'-triphosphate (ATP) were examined as inhibitors of human platelet aggregation. 2-Methylthio-AMP, 2-ethylthio-AMP, 2-(pentan-l-yl)thio-AMP, 2-ethylthio-AMPS, 2-methylthio-ATP and 2-ethylthio-ATP (100 microM) each inhibited aggregation induced by adenosine 5'-diphosphate (ADP) but not by 11 alpha, 9 alpha-epoxymethano prostaglandin H2, a stable endoperoxide analogue. Log dose-response curves to ADP in the absence and presence of each inhibitor were not parallel and the inhibition could not be overcome by high concentrations of ADP. The ATP analogues achieved greater inhibition of aggregation induced by ADP (5 microM) than did the AMP analogues. The order of potency of the AMP analogues was 2-ethylthio-AMPS greater than 2-ethylthio-AMP greater than 2-(pentan-l-yl)thio-AMP greater than 2-methylthio-AMP, and 2-methylthio-ATP was more potent than 2-ethylthio-ATP. These 2-alkylthio substituted analogues of AMP and ATP are specific but noncompetitive inhibitors of ADP-induced human platelet aggregation.